Abstract
The in vivo mechanism of regulatory T cell (Treg cell) function in controlling autoimmunity remains controversial. Here we have used two-photon laser-scanning microscopy to analyze lymph node priming of diabetogenic T cells and to delineate the mechanisms of Treg cell control of autoimmunity in vivo. Islet antigen–specific CD4+CD25− T helper cells (TH cells) and Treg cells swarmed and arrested in the presence of autoantigens. These TH cell activities were progressively inhibited in the presence of increasing numbers of Treg cells. There were no detectable stable associations between Treg and TH cells during active suppression. In contrast, Treg cells directly interacted with dendritic cells bearing islet antigen. Such persistent Treg cell–dendritic cell contacts preceded the inhibition of TH cell activation by dendritic cells, supporting the idea that dendritic cells are central to Treg cell function in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sakaguchi, S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345–352 (2005).
Chatenoud, L., Salomon, B. & Bluestone, J.A. Suppressor T cells–they're back and critical for regulation of autoimmunity! Immunol. Rev. 182, 149–163 (2001).
Wood, K.J. & Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199–210 (2003).
Singh, B. et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182, 190–200 (2001).
Curotto de Lafaille, M.A. & Lafaille, J.J. CD4+ regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14, 771–778 (2002).
Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455–1465 (2004).
Tarbell, K.V., Yamazaki, S., Olson, K., Toy, P. & Steinman, R.M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467–1477 (2004).
Thornton, A.M. & Shevach, E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296 (1998).
Piccirillo, C.A. et al. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196, 237–246 (2002).
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. & Schuler, G. Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J. Exp. Med. 193, 1303–1310 (2001).
Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756–763 (2002).
Levings, M.K., Sangregorio, R. & Roncarolo, M.G. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193, 1295–1302 (2001).
Jonuleit, H. et al. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285–1294 (2001).
Levings, M.K. et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196, 1335–1346 (2002).
Thornton, A.M. & Shevach, E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183–190 (2000).
Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995–1004 (1999).
Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
Kingsley, C.I., Karim, M., Bushell, A.R. & Wood, K.J. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080–1086 (2002).
Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach, E.M. & Sacks, D.L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507 (2002).
Stoll, S., Delon, J., Brotz, T.M. & Germain, R.N. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296, 1873–1876 (2002).
Mempel, T.R., Henrickson, S.E. & Von Andrian, U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154–159 (2004).
Miller, M.J., Wei, S.H., Parker, I. & Cahalan, M.D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296, 1869–1873 (2002).
Miller, M.J., Safrina, O., Parker, I. & Cahalan, M.D. Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J. Exp. Med. 200, 847–856 (2004).
Bousso, P. & Robey, E. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4, 579–585 (2003).
Itano, A.A. et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19, 47–57 (2003).
Itano, A.A. & Jenkins, M.K. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4, 733–739 (2003).
Schmidt, D., Verdaguer, J., Averill, N. & Santamaria, P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186, 1059–1075 (1997).
Stetson, D.B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069–1076 (2003).
Hara, M. et al. Transgenic mice with green fluorescent protein-labeled pancreatic β-cells. Am. J. Physiol. Endocrinol. Metab. 284, E177–E183 (2003).
Iezzi, G., Scotet, E., Scheidegger, D. & Lanzavecchia, A. The interplay between the duration of TCR and cytokine signaling determines T cell polarization. Eur. J. Immunol. 29, 4092–4101 (1999).
Gett, A.V., Sallusto, F., Lanzavecchia, A. & Geginat, J. T cell fitness determined by signal strength. Nat. Immunol. 4, 355–360 (2003).
Huppa, J.B., Gleimer, M., Sumen, C. & Davis, M.M. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4, 749–755 (2003).
Gunzer, M. et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity 13, 323–332 (2000).
Gunzer, M. et al. A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo. Blood 104, 2801–2809 (2004).
Hsieh, C.S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267–277 (2004).
Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003).
Scheinecker, C., McHugh, R., Shevach, E.M. & Germain, R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079–1090 (2002).
Serra, P. et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 19, 877–889 (2003).
Sanderson, M.J. & Parker, I. Video-rate confocal microscopy. Methods Enzymol. 360, 447–481 (2003).
Acknowledgements
We thank S. Jiang, C. McArthur, C. Bennett, R.A. Hwang, F. Siedenberg, L. Braun, J. Belgum, S. Hayden, M. Sanderson and M. Bengttson for technical assistance, and members of the Bluestone laboratory for support. Supported by the Juvenile Diabetes Research Foundation (4-1999-841 and 32004232), National Insitutes of Health (R37 AI46643, P30 DK063720, R21 AI066097 and AI30663), Sandler–Howard Hughes Medical Institute Biomedical Research Support Program (5300246), Sandler New Technologies and the Canadian Institutes of Health Research and Alberta Heritage Foundation for Medical Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
TPLSM survey of pancreatic LN for the presence and distribution of transferred cells in the pancreatic LN. (PDF 372 kb)
Supplementary Video 1
BDC2.5 TH cells in inguinal LN of NOD recipients. The trajectories for some randomly selected cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 15 minute in real-time, which is compressed to 5 sec in this video. (MOV 409 kb)
Supplementary Video 2
BDC2.5 TH cells in pancreatic LN of NOD recipients. The trajectories for some free moving (top half) and swarming (lower middle) cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 15 minute in real-time, which is compressed to 5 sec in this video. (MOV 359 kb)
Supplementary Video 3
BDC2.5 TH cells in pancreatic LN of a NOD.Cd28−/− recipient. The trajectories for some clustering and arrested cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 30 minute in real-time, which is compressed to 10 sec in this video. (MOV 727 kb)
Supplementary Video 4
BDC2.5 TH cells in pancreatic LN of a NOD.CD80−/−CD86−/− recipient. The trajectories for some clustering and arrested cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 30 minute in real-time, which is compressed to 10 sec in this video. (MOV 1155 kb)
Supplementary Video 5
BDC2.5 TH cells in pancreatic LN of a NOD.Cd28−/− recipient reconstituted with NOD Treg cells. The trajectories for some swarming cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 30 minute in real-time, which is compressed to 10 seconds in this video. (MOV 997 kb)
Supplementary Video 6
BDC2.5 TH cells in pancreatic LN of a NOD.Cd28−/− recipient reconstituted with BDC2.5 Treg cells. The trajectories for some randomly selected cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 30 minute in real-time, which is compressed to 10 sec in this video. (MOV 1415 kb)
Supplementary Video 7
Lack of stable interaction between Treg cells and TH cells during in vivo suppression. BDC2.5 TH cells (greenish yellow) and BDC2.5 Treg cells (red) in pancreatic LN of a NOD.Cd28−/− recipient were imaged together showing lack of stable association of the two cell types. This duration of the imaging is 6 minute in real-time, which is compressed to 4 sec in this video. (MOV 414 kb)
Supplementary Video 8
BDC2.5 TH cells (red) interacting with GFP+ DCs in the pancreatic LN of a NOD.MIP.GFP recipient. This video is generated by projecting 10 images spanning 20 μm in the z direction onto a single plane. The duration of this imaging is 15 minute in real-time, which is compressed to 5 sec in this video. (MOV 180 kb)
Supplementary Video 9
BDC2.5 Treg cells in pancreatic LN of NOD recipients. The trajectories for some swarming cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 30 minute in real-time, which is compressed to 10 sec in this video. (MOV 1107 kb)
Supplementary Video 10
BDC2.5 Treg cells in pancreatic LN of a NOD.Cd28−/− recipient. The trajectories for some clustering cells are shown. The tracks are color coded to indicate time progression from the beginning (blue) to the end of imaging (yellow). The duration of the imaging is 15 minute in real-time, which is compressed to 4.5 sec in this video. (MOV 736 kb)
Supplementary Video 11
BDC2.5 Treg cells (red) interacting with a GFP+ DC in the pancreatic LN of a NOD.MIP.GFP recipient. This video is generated by projecting 10 images spanning 24 μm in the z direction onto a single plane. The duration of the imaging is 10 minute in real-time, which is compressed to 3 sec in this video. (MOV 195 kb)
Rights and permissions
About this article
Cite this article
Tang, Q., Adams, J., Tooley, A. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7, 83–92 (2006). https://doi.org/10.1038/ni1289
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1289
This article is cited by
-
Lentinan confers protection against type 1 diabetes by inducing regulatory T cell in spontaneous non-obese diabetic mice
Nutrition & Diabetes (2023)
-
Localization and movement of Tregs in gastrointestinal tract: a systematic review
Inflammation and Regeneration (2022)
-
NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes
Cell Death & Disease (2022)
-
Isolation, chemical characterization and in vitro bioactive potential of polysaccharides from seaweed Portieria hornemannii
Biomass Conversion and Biorefinery (2022)
-
Continuous stimulation of dual-function peptide PGLP-1-VP inhibits the morbidity and mortality of NOD mice through anti-inflammation and immunoregulation
Scientific Reports (2021)